<VariationArchive RecordType="classified" VariationID="375002" VariationName="NM_172107.4(KCNQ2):c.1680_1684dup (p.Tyr562fs)" VariationType="Duplication" Accession="VCV000375002" Version="1" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-05-24" DateCreated="2013-04-04" MostRecentSubmission="2018-01-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="361908" VariationID="375002">
      <GeneList>
        <Gene Symbol="KCNQ2" FullName="potassium voltage-gated channel subfamily Q member 2" GeneID="3785" HGNC_ID="HGNC:6296" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63400208" stop="63472655" display_start="63400208" display_stop="63472655" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NT_187625.1" start="183" stop="33239" display_start="183" display_stop="33239" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62037541" stop="62103992" display_start="62037541" display_stop="62103992" Strand="-" />
          </Location>
          <OMIM>602235</OMIM>
          <Haploinsufficiency last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_172107.4(KCNQ2):c.1680_1684dup (p.Tyr562fs)</Name>
      <CanonicalSPDI>NC_000020.11:63413528:AGGGC:AGGGCAGGGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>20q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63413528" stop="63413529" display_start="63413528" display_stop="63413529" variantLength="5" positionVCF="63413528" referenceAlleleVCF="T" alternateAlleleVCF="TAGGGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62044881" stop="62044882" display_start="62044881" display_stop="62044882" variantLength="5" positionVCF="62044881" referenceAlleleVCF="T" alternateAlleleVCF="TAGGGC" />
      </Location>
      <ProteinChange>Y531fs</ProteinChange>
      <ProteinChange>Y544fs</ProteinChange>
      <ProteinChange>Y562fs</ProteinChange>
      <ProteinChange>Y534fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172107.2" sequenceAccession="NM_172107" sequenceVersion="2" change="c.1684_1685dupGCCCT">
            <Expression>NM_172107.2:c.1684_1685dupGCCCT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.62044882_62044886dup" Assembly="GRCh37">
            <Expression>NC_000020.10:g.62044882_62044886dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.63413529_63413533dup" Assembly="GRCh38">
            <Expression>NC_000020.11:g.63413529_63413533dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009004.2" sequenceAccession="NG_009004" sequenceVersion="2" change="g.64108_64112dup">
            <Expression>NG_009004.2:g.64108_64112dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004518.6" sequenceAccession="NM_004518" sequenceVersion="6" change="c.1596_1600dup">
            <Expression>NM_004518.6:c.1596_1600dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004509.2" sequenceAccession="NP_004509" sequenceVersion="2" change="p.Tyr534fs">
            <Expression>NP_004509.2:p.Tyr534fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172106.3" sequenceAccession="NM_172106" sequenceVersion="3" change="c.1626_1630dup">
            <Expression>NM_172106.3:c.1626_1630dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742104.1" sequenceAccession="NP_742104" sequenceVersion="1" change="p.Tyr544fs">
            <Expression>NP_742104.1:p.Tyr544fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172107.4" sequenceAccession="NM_172107" sequenceVersion="4" change="c.1680_1684dup" MANESelect="true">
            <Expression>NM_172107.4:c.1680_1684dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742105.1" sequenceAccession="NP_742105" sequenceVersion="1" change="p.Tyr562fs">
            <Expression>NP_742105.1:p.Tyr562fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172108.5" sequenceAccession="NM_172108" sequenceVersion="5" change="c.1587_1591dup">
            <Expression>NM_172108.5:c.1587_1591dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742106.1" sequenceAccession="NP_742106" sequenceVersion="1" change="p.Tyr531fs">
            <Expression>NP_742106.1:p.Tyr531fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340675" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602235.0003" DB="OMIM" />
        <XRef Type="rs" ID="118192231" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_172107.4(KCNQ2):c.1680_1684dup (p.Tyr562fs) AND Seizures, benign familial neonatal, 1" Accession="RCV000415727" Version="3">
        <ClassifiedConditionList TraitSetID="2010">
          <ClassifiedCondition DB="MedGen" ID="C3149074">Seizures, benign familial neonatal, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-03-31" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-03-31" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2018-01-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25982755</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7980108</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9430594</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20437616</ID>
          <ID Source="BookShelf">NBK32534</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2010" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5025" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Benign Neonatal Epilepsy 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">KCNQ2-Related Benign Familial Neonatal Epilepsy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Seizures, benign familial neonatal, 1</ElementValue>
                <XRef ID="MONDO:0007365" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BFNS1</ElementValue>
                <XRef Type="MIM" ID="121200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">KCNQ2-related disorders represent a continuum of overlapping neonatal epileptic phenotypes ranging from self-limited familial neonatal epilepsy (SLFNE) at the mild end to neonatal-onset developmental and epileptic encephalopathy (NEO-DEE) at the severe end. Additional, less common phenotypes consisting of neonatal encephalopathy with non-epileptic myoclonus, infantile or childhood-onset developmental and epileptic encephalopathy (DEE), and isolated intellectual disability (ID) without epilepsy have also been described. KCNQ2-SLFNE is characterized by seizures that start in otherwise healthy infants between two and eight days after term birth and spontaneously disappear between the first and the sixth to 12th month of life. There is always a seizure-free interval between birth and the onset of seizures. Seizures are characterized by sudden onset with prominent motor involvement, often accompanied by apnea and cyanosis; video EEG identifies seizures as focal onset with tonic stiffening of limb(s) and some migration during each seizure's evolution. About 30% of individuals with KCNQ2-SLFNE develop epileptic seizures later in life. KCNQ2-NEO-DEE is characterized by multiple daily seizures beginning in the first week of life that are mostly tonic, with associated focal motor and autonomic features. Seizures generally cease between ages nine months and four years. At onset, EEG shows a burst-suppression pattern or multifocal epileptiform activity; early brain MRI can show basal ganglia hyperdensities and later MRIs may show white matter or general volume loss. Moderate-to-profound developmental impairment is present.</Attribute>
                <XRef ID="NBK32534" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20437616</ID>
                <ID Source="BookShelf">NBK32534</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="1949" DB="Orphanet" />
              <XRef ID="C3149074" DB="MedGen" />
              <XRef ID="MONDO:0007365" DB="MONDO" />
              <XRef Type="MIM" ID="121200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="41619" SubmissionDate="2016-03-31" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_172107.2:c.1684_1685dupGCCCT|OMIM:121200" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000041619" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-31">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9430594</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25982755</ID>
          </Citation>
          <Citation>
            <URL>http://www.ncbi.nlm.nih.gov/books/NBK32534/</URL>
          </Citation>
          <Comment Type="public">BFNE (benign familial neonatal epilepsy)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_172107.2:c.1684_1685dupGCCCT</Name>
            <Name>p.Tyr562CysfsTer4</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_172107.2:c.1684_1685dupGCCCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="121200" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">Functional effect: Lack of functional homomeric channels; reduction maximal current amplitude of heteromeric channels</Comment>
      </ClinicalAssertion>
      <ClinicalAssertion ID="28009" SubmissionDate="2018-01-17" DateLastUpdated="2018-01-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602235.0003_SEIZURES, BENIGN FAMILIAL NEONATAL, 1" title="KCNQ2, 5-BP INS_SEIZURES, BENIGN FAMILIAL NEONATAL, 1" />
        <ClinVarAccession Accession="SCV000028009" DateUpdated="2018-01-20" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-01-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Biervert et al. (1998) identified an insertional mutation in the KCNQ2 gene in a large Australian Caucasian pedigree with benign familial neonatal seizures (BFNS1; 121200) previously reported by Berkovic et al. (1994). Biervert et al. (1998) found a heterozygous 5-bp insertion at the triplet encoding amino acid 534 in a segment highly conserved between KCNQ2 and KCNQ1 (607542), which is mutated in type 1 long QT syndrome (192500). The resulting frameshift was predicted to cause a premature stop, which would truncate more than 300 amino acids. Of 13 affected family members, 10 had known neonatal seizures. Two patients had afebrile seizures later, 1 of whom did not have neonatal seizures. One mutation carrier was unaffected, indicating reduced penetrance. Berkovic et al. (1994) noted the phenotypic heterogeneity in this family.</Attribute>
              <Citation>
                <ID Source="PubMed">9430594</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7980108</ID>
              </Citation>
              <XRef DB="OMIM" ID="121200" Type="MIM" />
              <XRef DB="OMIM" ID="607542" Type="MIM" />
              <XRef DB="OMIM" ID="192500" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <Name>KCNQ2, 5-BP INS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP INS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602235.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SEIZURES, BENIGN FAMILIAL NEONATAL, 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="41619" TraitType="Disease" MappingType="XRef" MappingValue="121200" MappingRef="OMIM">
        <MedGen CUI="C3149074" Name="Seizures, benign familial neonatal, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28009" TraitType="Disease" MappingType="Name" MappingValue="SEIZURES, BENIGN FAMILIAL NEONATAL, 1" MappingRef="Preferred">
        <MedGen CUI="C3149074" Name="Seizures, benign familial neonatal, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

